Gilead Sciences' revenue 2006-2019

Gilead Sciences' total revenue in 2019 amounted to slightly over 22.4 billion U.S. dollars. The statistic illustrates Gilead Sciences revenue from 2006 to 2019. The company recently shot to the public spotlight for its drug remdesivir, which is being trialed as a treatment for the coronavirus disease 2019.

Gilead Sciences' revenue from 2006 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Worldwide

Survey time period

2006 to 2019

Supplementary notes

Figures for 2006-2014 were quoted from previous annual reports.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotech industry"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.